Who
Frank X. Leonard
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, NovoCure.
In numbers
- Trades disclosed
- 116
- Buys
- 0
- Sells
- 41
- Bought
- $0
- Sold
- $15.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Sep 2020
- Last trade
- 30 Jun 2026
- Last filed
- 1 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jun 2026filed 1 Jul 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | $21K1,905 at $11.15 | filing |
| 30 Jun 2026filed 1 Jul 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | $21K1,905 at $11.15 | filing |
| 4 Jun 2026filed 5 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $615K34,273 at $17.93 | filing |
| 4 Jun 2026filed 5 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $615K34,273 at $17.93 | filing |
| 4 Mar 2026filed 5 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $75K5,607 at $13.31 | filing |
| 4 Mar 2026filed 5 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $75K5,607 at $13.31 | filing |
| 3 Mar 2026filed 5 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —216,388 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —216,388 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $98K7,232 at $13.49 | filing |
| 2 Mar 2026filed 3 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $98K7,232 at $13.49 | filing |
| 28 Feb 2026filed 3 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —18,621 at $0.00 | filing |
| 28 Feb 2026filed 3 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —18,621 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $133K9,734 at $13.66 | filing |
| 27 Feb 2026filed 3 Mar 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $133K9,734 at $13.66 | filing |
| 1 Nov 2025filed 4 Nov 2025 | NVCR NovoCureMedical Devices | SEC FORM 4 Code F | $12K966 at $12.81 | filing |
| 30 Jun 2025filed 1 Jul 2025 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | $13K833 at $15.13 | filing |
| 4 Jun 2025filed 6 Jun 2025 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —179,426 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $374K21,717 at $17.22 | filing |
News
Reviewing NeurAxis (NASDAQ:NRXS) & NovoCure (NASDAQ:NVCR)NVCR · tickerreport.com · 15 Oct 2026NovoCure (NASDAQ:NVCR) and Medline (NASDAQ:MDLN) Financial AnalysisNVCR · themarketsdaily.com · 8 Oct 2026NovoCure (NASDAQ:NVCR) versus Kewaunee Scientific (NASDAQ:KEQU) Head-To-Head ReviewNVCR · dailypolitical.com · 7 Oct 2026
0 headlines in the last 90 days name Frank X. Leonard; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.